FdaApplication
NDA 220613
Identifiers
- fda_app_no: NDA220613
Properties
| Property | Value |
|---|---|
| applicant_name | HANDA ONCOL |
| application_type | NDA |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OMCAZIO | CABOZANTINIB LAURYLSULFATE | EQ 23MG BASE | CAPSULE;ORAL |
| OMCAZIO | CABOZANTINIB LAURYLSULFATE | EQ 11.5MG BASE | CAPSULE;ORAL |
| OMCAZIO | CABOZANTINIB LAURYLSULFATE | EQ 34.5MG BASE | CAPSULE;ORAL |
3 products